Kan Sheng-Yuan, Scarpini Cinzia G, Ward Dawn, Fleming Ben, Cheow Heok K, Jalloh Ibrahim, Tadross John A, Watkins James, Roberts Thomas, Trotman Jamie, Tarpey Patrick, Coleman Nicholas, Hook C Elizabeth, Burns Charlotte, Trayers Claire, Murray Matthew J
Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Department of Pathology, University of Cambridge, Cambridge, UK.
Pediatr Dev Pathol. 2025 Jul-Aug;28(4):338-345. doi: 10.1177/10935266251335391. Epub 2025 Apr 25.
NUT carcinoma is challenging to diagnose and may mimic a germ cell tumor (GCT) due to raised serum alpha-fetoprotein (AFP). A 15-year-old patient presented with back pain and cough. Investigation revealed a mediastinal mass and multiple bone metastases. Serum AFP was highly elevated, consistent with a metastatic malignant nonseminomatous GCT. Aggressive chemotherapy was initiated with initial response, unfortunately not sustained. Diagnostic biopsy showed undifferentiated tumor cells with weak GCT immunophenotype but was ultimately non-diagnostic. Serum miR-371a-3p levels, highly sensitive/specific for malignant GCTs, were negative casting diagnostic suspicion. Routine use of agnostic molecular investigations, including whole genome sequencing, identified a chromosome 15:19 translocation, with gene fusion on RNA sequencing, confirming NUT carcinoma. Subsequent NUTM1 immunohistochemistry was positive. A high index of clinical suspicion is required for non-pathologically/molecularly confirmed diagnoses. Serum miR-371a-3p quantification ruled out malignant GCT and routine agnostic molecular studies identified the correct diagnosis; a low threshold for NUTM1 immunohistochemistry is thus recommended.
NUT癌的诊断具有挑战性,由于血清甲胎蛋白(AFP)升高,它可能会被误诊为生殖细胞肿瘤(GCT)。一名15岁患者出现背痛和咳嗽症状。检查发现纵隔肿块和多处骨转移。血清AFP高度升高,符合转移性恶性非精原细胞瘤性GCT的表现。于是开始进行积极的化疗,最初有反应,但遗憾的是未能持续。诊断性活检显示未分化肿瘤细胞,具有较弱的GCT免疫表型,但最终未能确诊。血清miR-371a-3p水平对恶性GCT具有高度敏感性/特异性,结果为阴性,这引发了诊断怀疑。常规使用包括全基因组测序在内的非特异性分子检测方法,发现了15号染色体与19号染色体的易位,RNA测序显示有基因融合,从而确诊为NUT癌。随后进行的NUTM1免疫组化检查呈阳性。对于非经病理/分子确诊的病例,需要高度的临床怀疑。血清miR-371a-3p定量检测排除了恶性GCT,常规的非特异性分子研究确定了正确诊断;因此建议对NUTM1免疫组化检查采用较低的阈值。